BindingDB logo
myBDB logout

182 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
27888721 14 Discovery of resveratrol derivatives as novel LSD1 inhibitors: Design, synthesis and their biological evaluation.EBI Xinxiang Medical University
28435523 9 Discovery of [1,2,3]Triazolo[4,5-EBI Key Laboratory of Technology of Drug Preparation (Zhengzhou University)
28065500 8 Activation of lysine-specific demethylase 1 inhibitor peptide by redox-controlled cleavage of a traceless linker.EBI Nagoya City University
27046190 10 Impact of Binding Site Comparisons on Medicinal Chemistry and Rational Molecular Design.EBI Tu Dortmund University
27105028 1 Efficient synthesis of new antiproliferative steroidal hybrids using the molecular hybridization approach.EBI Zhengzhou University
26710088 248 Recent Progress in Histone Demethylase Inhibitors.EBI University of Oxford
26819657 8 Cyclopropanamine Compounds and Use Thereof.EBI Temple University
26700437 32 Identification of SNAIL1 Peptide-Based Irreversible Lysine-Specific Demethylase 1-Selective Inactivators.EBI Kyoto Prefectural University of Medicine
26794039 12 Evaluation of phenylcyclopropylamine compounds by enzymatic assay of lysine-specific demethylase 2 in the presence of NPAC peptide.EBI Waseda University
26652247 60 3-(Piperidin-4-ylmethoxy)pyridine Containing Compounds Are Potent Inhibitors of Lysine Specific Demethylase 1.EBI Baylor College of Medicine
26086931 38 Strategies for the Discovery of Target-Specific or Isoform-Selective Modulators.EBI Shandong University
25699146 13 Pure Diastereomers of a Tranylcypromine-Based LSD1 Inhibitor: Enzyme Selectivity and In-Cell Studies.EBI Sapienza University of Rome
25768700 30 Pure enantiomers of benzoylamino-tranylcypromine: LSD1 inhibition, gene modulation in human leukemia cells and effects on clonogenic potential of murine promyelocytic blasts.EBI Sapienza University of Rome
25610955 53 Design, synthesis, and structure-activity relationship of novel LSD1 inhibitors based on pyrimidine-thiourea hybrids as potent, orally active antitumor agents.EBI Zhengzhou University
25827526 33 Histone H3 peptide based LSD1-selective inhibitors.EBI Waseda University
25725609 18 Structure-activity study for (bis)ureidopropyl- and (bis)thioureidopropyldiamine LSD1 inhibitors with 3-5-3 and 3-6-3 carbon backbone architectures.EBI John Hopkins University
25173853 50 Synthesis, biological activity and mechanistic insights of 1-substituted cyclopropylamine derivatives: a novel class of irreversible inhibitors of histone demethylase KDM1A.EBI European Institute of Oncology
24883177 10 Synthesis and evaluation of novel cyclic Peptide inhibitors of lysine-specific demethylase 1.EBI Medical University of South Carolina
24237195 46 High-throughput virtual screening identifies novel N'-(1-phenylethylidene)-benzohydrazides as potent, specific, and reversible LSD1 inhibitors.EBI University of Utah
24131029 90 Triazole-dithiocarbamate based selective lysine specific demethylase 1 (LSD1) inactivators inhibit gastric cancer cell growth, invasion, and migration.EBI Zhengzhou University
24007511 10 Nonpeptidic propargylamines as inhibitors of lysine specific demethylase 1 (LSD1) with cellular activity.EBI University of Freiburg
22876979 2 Low molecular weight amidoximes that act as potent inhibitors of lysine-specific demethylase 1.EBI Wayne State University
22975593 62 Oncoepigenomics: making histone lysine methylation count.EBI TBA
20568780 2 (Bis)urea and (bis)thiourea inhibitors of lysine-specific demethylase 1 as epigenetic modulators.EBI Wayne State University
21955276 60 Lysine demethylases inhibitors.EBI Kyoto Prefectural University of Medicine
21596573 46 Inhibitors of histone demethylases.EBI University of Copenhagen
21382717 19 Enantioselective synthesis of tranylcypromine analogues as lysine demethylase (LSD1) inhibitors.EBI University of Southampton
21227703 3 Synthesis and biological activity of optically active NCL-1, a lysine-specific demethylase 1 selective inhibitor.EBI Nagoya City University
32551003 53 Design and Synthesis of Styrenylcyclopropylamine LSD1 Inhibitors.EBI Constellation Pharmaceuticals
32201021 15 4-Hydroxy-3-methylbenzofuran-2-carbohydrazones as novel LSD1 inhibitors.EBI Liaocheng University
32435381 33 Discovery of Reversible Inhibitors of KDM1A Efficacious in Acute Myeloid Leukemia Models.EBI European Institute of Oncology Irccs
32435375 22 New Dual CK2/HDAC1 Inhibitors with Nanomolar Inhibitory Activity against Both Enzymes.EBI Universidad San Pablo-Ceu
27524309 62 Synthesis and biological evaluation of novel (E)-N'-(2,3-dihydro-1H-inden-1-ylidene) benzohydrazides as potent LSD1 inhibitors.EBI Sichuan University
30739825 32 Experience-based discovery (EBD) of aryl hydrazines as new scaffolds for the development of LSD1/KDM1A inhibitors.EBI Zhengzhou University
31096156 55 Discovery and synthesis of novel indole derivatives-containing 3-methylenedihydrofuran-2(3H)-one as irreversible LSD1 inhibitors.EBI Zhengzhou University
30780087 32 Synthesis, structure-activity relationship studies and biological characterization of new [1,2,4]triazolo[1,5-a]pyrimidine-based LSD1/KDM1A inhibitors.EBI Zhengzhou University
30713023 51 Tranylcypromine and 6-trifluoroethyl thienopyrimidine hybrid as LSD1 inhibitor.EBI Liaoning Shihua University
30611617 15 Identification of selective and reversible LSD1 inhibitors with anti-metastasis activity by high-throughput docking.EBI Taizhou People'S Hospital
30472603 11 Ligand-based design, synthesis and biological evaluation of xanthine derivatives as LSD1/KDM1A inhibitors.EBI Zhengzhou University
30850265 6 Inhibition of the FAD containing ER oxidoreductin 1 (Ero1) protein by EN-460 as a strategy for treatment of multiple myeloma.EBI West Virginia University
31627991 35 Design, synthesis and biological evaluation of curcumin analogues as novel LSD1 inhibitors.EBI Shenyang Pharmaceutical University
30552007 18 Flavone-based natural product agents as new lysine-specific demethylase 1 inhibitors exhibiting cytotoxicity against breast cancer cells in vitro.EBI China Pharmaceutical University
30448189 28 Design, synthesis and in vitro evaluation of stilbene derivatives as novel LSD1 inhibitors for AML therapy.EBI Xinxiang Medical University
30409536 50 Structure-based design and discovery of potent and selective lysine-specific demethylase 1 (LSD1) inhibitors.EBI Celgene
25580204 10 3,5-Diamino-1,2,4-triazoles as a novel scaffold for potent, reversible LSD1 (KDM1A) inhibitors.EBI Medical University of South Carolina
23293738 2 Polyamine-based small molecule epigenetic modulators.EBI Wayne State University
24325601 74 Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities.EBI Sapienza University of Rome
19534534 3 Recent advances in the development of polyamine analogues as antitumor agents.EBI Johns Hopkins University
29247860 80 Structure-activity studies on N-Substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiation.EBI University of Freiburg
30153955 20 Optimization of 5-arylidene barbiturates as potent, selective, reversible LSD1 inhibitors for the treatment of acute promyelocytic leukemia.EBI Fudan University
29627262 109 Structure-based design and discovery of potent and selective KDM5 inhibitors.EBI Celgene
29439916 1 New histone demethylase LSD1 inhibitor selectively targets teratocarcinoma and embryonic carcinoma cells.EBI University of Nevada
29331452 9 Design, synthesis and evaluation of ?-turn mimetics as LSD1-selective inhibitors.EBI Kyoto Prefectural University of Medicine
29198865 9 Histone H3 peptides incorporating modified lysine residues as lysine-specific demethylase 1 inhibitors.EBI Waseda University
29037950 21 Discovery of tranylcypromine analogs with an acylhydrazone substituent as LSD1 inactivators: Design, synthesis and their biological evaluation.EBI Zhengzhou University
29152043 6 Lysine-Specific Demethylase 1 (LSD1) Inhibitors as Potential Treatment for Different Types of Cancers.EBI Therachem Research Medilab (India)
29031059 61 Tying up tranylcypromine: Novel selective histone lysine specific demethylase 1 (LSD1) inhibitors.EBI East China Normal University
28987602 38 Design and synthesis of tranylcypromine derivatives as novel LSD1/HDACs dual inhibitors for cancer treatment.EBI Xinxiang Medical University
28927796 42 Development and evaluation of 4-(pyrrolidin-3-yl)benzonitrile derivatives as inhibitors of lysine specific demethylase 1.EBI University of Manchester
27769034 36 Design, synthesis and biological evaluation of [1,2,4]triazolo[1,5-a]pyrimidines as potent lysine specific demethylase 1 (LSD1/KDM1A) inhibitors.EBI Zhengzhou University
28390942 27 Fluorinated tranylcypromine analogues as inhibitors of lysine-specific demethylase 1 (LSD1, KDM1A).EBI University of East Anglia
28610981 66 3D-QSAR (CoMFA, CoMSIA), molecular docking and molecular dynamics simulations study of 6-aryl-5-cyano-pyrimidine derivatives to explore the structure requirements of LSD1 inhibitors.EBI Zhengzhou University
28512031 65 From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors.EBI Genentech
28545974 70 Development of 5-hydroxypyrazole derivatives as reversible inhibitors of lysine specific demethylase 1.EBI University of Manchester
28892629 74 Development of (4-Cyanophenyl)glycine Derivatives as Reversible Inhibitors of Lysine Specific Demethylase 1.EBI University of Manchester
28336409 14 Development and crystallographic evaluation of histone H3 peptide with N-terminal serine substitution as a potent inhibitor of lysine-specific demethylase 1.EBI Nagoya City University
28460360 13 Design, synthesis and biological activity of 3-oxoamino-benzenesulfonamides as selective and reversible LSD1 inhibitors.BDB China Pharmaceutical University
25346381 6 Identification of Novel Selective Lysine-Specific Demethylase 1 (LSD1) Inhibitors Using a Pharmacophore-Based Virtual Screening Combined with Docking.BDB China Pharmaceutical University
24707965 33 A Selective Phenelzine Analogue Inhibitor of Histone Demethylase LSD1.BDB Johns Hopkins University
20568732 14 Structurally designed trans-2-phenylcyclopropylamine derivatives potently inhibit histone demethylase LSD1/KDM1 .BDB Riken Systems and Structural Biology Center